Feasibility of autologous stem cell transplant followed by reduced intensity allogeneic stem cell transplantation for high risk neuroblastoma: A single institution pilot study

被引：0
|
作者：
Yalizasbiro, D. J. [1 ]
Lee, A. [1 ]
Bhatia, M. [1 ]
Glade-Bender, J. [1 ]
Qualter, E. [1 ]
Militano, O. [1 ]
Harrison, L. A. [1 ]
Davenport, V. [1 ]
Cheung, K. [1 ]
Bradley, M. B. [1 ]
Garvin, J. H. [1 ]
Del Toro, G. [1 ]
Cairo, M. S. [1 ]
机构：
[1] Columbia Univ, New York, NY USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2007年 / 13卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
185
引用
收藏
页码：68 / 69
页数：2
相关论文
共 50 条
  • [31] Reduced intensity allogeneic stem cell transplantation in patients with myelofibrosis
    Bloor, AJC
    Ahmed, O
    Dimpoulou, M
    Fielding, AK
    Chakraverty, R
    Parker, AN
    Liakopoulou, E
    Goldstone, AH
    Thomson, K
    Mackinnon, S
    Kottaridis, P
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 13 - 13
  • [32] Reduced intensity allogeneic stem cell transplantation in multiple myeloma
    Bensinger, William I.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 4384 - 4392
  • [33] Reduced-intensity conditioning followed by allogeneic stem cell transplant for patients with malignant lymphoma - A single center experience
    Valkova, V
    Vitek, A
    Markova, M
    Cetkovsky, P
    ANNALS OF ONCOLOGY, 2005, 16 : 186 - 186
  • [34] Induction Bortezomib in AL Amyloidosis Followed By High Dose Melphalan and Autologous Stem Cell Transplantation: A Single Institution Retrospective Study
    Scott, Emma C.
    Heitner, Stephen B.
    Dibb, William
    Meyers, Gabrielle
    Smith, Stephen D.
    Abar, Famoush
    Kovacsovics, Tibor
    Perez-Avraham, Galit
    Stentz, Alex
    Frires, Rachel
    Dibb, James
    Maziarz, Richard T.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (05): : 424 - 430
  • [35] ALLOGENEIC STEM CELL TRANSPLANTATION FOR POST-AUTOLOGOUS STEM CELL TRANSPLANT RELAPSE IN HODGKIN LYMPHOMA: EXPERIENCE AT A SINGLE CENTER
    Oliva, J. L.
    Kelly, J. L.
    Liesveld, J. L.
    Becker, M. W.
    Phillips, G. L.
    Sensenig, E.
    Constine, L.
    Bernstein, S. H.
    Fisher, R., I
    Friedberg, J. W.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 66 - 66
  • [36] Reduced intensity conditioning regimen and allogeneic stem cell transplantation from related or unrelated HLA identical donor in high risk neuroblastoma
    Prete, A.
    Rondelli, R.
    Locatelli, F.
    Lanino, E.
    Favre, C.
    Rabusin, M.
    Pession, A.
    Fagioli, F.
    EJC SUPPLEMENTS, 2009, 7 (02): : 223 - 223
  • [37] Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation
    Evgenii Shumilov
    Inna Shakhanova
    Johanna Flach
    Nicole Schmidt
    Susanne Buerki
    Myriam Legros
    Marie-Noëlle Kronig
    Yishai Ofran
    Sabine Gerull
    Michael Medinger
    Behrouz Mansouri Taleghani
    Jakob Passweg
    Jörg Halter
    Ulrike Bacher
    Thomas Pabst
    Bone Marrow Transplantation, 2022, 57 : 224 - 231
  • [38] Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation
    Shumilov, Evgenii
    Shakhanova, Inna
    Flach, Johanna
    Schmidt, Nicole
    Buerki, Susanne
    Legros, Myriam
    Kronig, Marie-Noelle
    Ofran, Yishai
    Gerull, Sabine
    Medinger, Michael
    Taleghani, Behrouz Mansouri
    Passweg, Jakob
    Halter, Joerg
    Bacher, Ulrike
    Pabst, Thomas
    BONE MARROW TRANSPLANTATION, 2022, 57 (02) : 224 - 231
  • [39] Salvage of multiple myeloma patients relapse after an autologous stem cell transplantation, in the era of thalidomide and reduced-intensity allogeneic stem cell transplantation
    Hardan, I
    Kneller, A
    Shimoni, A
    Berkowicz, M
    Avigdor, A
    Yeshurun, M
    Raanani, P
    Davidowich, Y
    Shemtov, N
    Ben Bassat, I
    Nagler, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S156 - S157
  • [40] The use of reduced intensity allogeneic stem cell transplantation (alloSCT) for recurrence after autologous stem cell transplantation (ASCT) in Hodgkin's disease (HD).
    Krishnan, AY
    Nademanee, A
    Fung, HC
    Popplewell, L
    Rodriguez, R
    Al Kadhimi, Z
    Kirschbaum, M
    Kogut, N
    Raubitschek, A
    Schriber, J
    Zain, J
    Smith, E
    Cheng, N
    Qian, DJ
    Molina, A
    Forman, SJ
    BLOOD, 2004, 104 (11) : 362B - 362B
12345